CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Central Nervous System Neoplasms
  • Cranial Irradiation
  • Lymphoma, Non-Hodgkin

abstract

  • This regimen did improve the survival of PCNSL patients but also caused substantial toxicity. The improvement in survival is less than that reported with high-dose methotrexate-based therapies.

publication date

  • October 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4335722

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2010.06.002

PubMed ID

  • 20800387

Additional Document Info

start page

  • 476

end page

  • 82

volume

  • 81

number

  • 2